Aziz Moqrich has been awarded the SATT IMPACT 2022 Prize for his team’s work on the TAFA4 protein Dr Moqrich is Research Director at the IBDM laboratory (part of the CNRS, the French National Center for Scientific Research) and cofounder of Tafalgie Therapeutics. Th award recognizes the major discoveries he and his team have made, […]

Lire la suite
Visit our contact page